Specific binding of [3H]19-nortestosterone in the 100000 g cytosol of the rat bulbocavernosus/levator ani muscle (BCLA) and prostate was demonstrated by agargel electrophoresis at low temperature and compared qualitatively and quantitatively with the binding of tritiated testosterone and 5α-dihydrotestosterone (5α-DHT). Both tissues showed a greater binding affinity for 5α-DHT than for 19-nortestosterone, with testosterone binding the least well of the three. The relative binding affinities in the BCLA and prostate were: 19-nortestosterone: testosterone = 1·4, 19-nortestosterone: 5α-DHT = 0·7. The differences were statistically significant (P < 0·02). The concentrations of receptor sites for 5α-DHT were 171 ± 20 (s.d.) fmol/mg prostatic cytosol protein and 24 ± 4 (s.d.) fmol/mg BCLA cytosol protein. The in-vitro metabolism of the three steroids in both tissues was also investigated by thin-layer chromatography. After incubating for 2 h at 0 °C the prostate was shown to reduce 26% of the 5α-DHT to androstanediols whilst the BCLA showed a 5% conversion. Testosterone was converted by the prostate to 5α-DHT (10%) and the androstanediols (6%) whilst the BCLA showed little activity in this respect. Comparing these in-vitro data with in-vivo findings from the literature, in both organs there is a positive correlation of the extent of binding in vitro to the stimulation of growth in vivo, bearing in mind that testosterone is metabolized to 5α-DHT in the prostate whilst in the BCLA, 5α-reductase is essentially absent.
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 2 | 1 | 0 |
| PDF Downloads | 0 | 0 | 0 |
Online ISSN: 1479-6805
Print ISSN: 0022-0795
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519
